Both in Pharmaceuticals
ANI Pharmaceuticals vs Stoke Therapeutics
Over the past year ANIP returned −21.0% and STOK returned +4.7%; their daily moves had a correlation of 0.02.
ANIP −21.0% STOK +4.7%Growth of $1, one year, split-adjusted
| Metric | ANIP | STOK |
|---|---|---|
| Price | $72.62 | $25.88 |
| Market cap | $1.67B | $1.67B |
| Today | −2.95% | +1.49% |
| 1 month | −0.3% | −18.2% |
| 6 months | −1.5% | −18.5% |
| Year to date | −8.0% | −18.5% |
| 1 year | −22.0% | +7.2% |
| Revenue growth (YoY) | +25.9% | −32.5% |
| Gross margin | 62.4% | 100.0% |
| Net margin | 8.6% | −660.8% |
| P/E (TTM) | 16.7× | — |
| Price / sales | 1.7× | 60.5× |
| Net cash | -$234.7M | $292.8M |
| Dividend yield | — | — |
| Volatility (60d) | 30.1% | 47.2% |
| Short % of float | 13.0% | 22.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).